HTS(High-Throughput Screening) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The High-Throughput Screening Market size is expected to reach USD 85.56 Billion in 2034 from USD 35.38 Billion (2025) growing at a CAGR of 10.31% during 2026-2034.

The Global High-Throughput Screening Market is expanding as pharmaceutical and biotechnology companies focus on accelerating drug discovery processes. High-throughput screening technologies allow researchers to test thousands of compounds quickly and efficiently, reducing the time required for early-stage drug development. The increasing prevalence of complex diseases is pushing companies to invest in faster and more precise screening solutions.

Major growth drivers include rising research and development spending and advancements in automation technologies. Robotics, data analytics, and improved assay technologies are enhancing screening accuracy and efficiency. Academic research institutes and contract research organizations are also contributing to market growth by adopting advanced screening platforms. Additionally, collaborations between pharmaceutical companies and technology providers are supporting innovation in this field.

Future prospects for the market remain promising, with continuous technological advancements improving screening speed and cost-effectiveness. The growing interest in personalized medicine and targeted therapies will further increase demand for high-throughput solutions. As drug pipelines expand and research becomes more data-driven, high-throughput screening will remain a critical tool in modern pharmaceutical development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

• Instrument
• Consumables
• Software & Services

By Technology

• Cell based assays
• Lab-on-chip technology
• Others

By Application

• Drug discovery
• Biochemical screening
• Others

COMPANIES PROFILED

• BioRad Laboratories Inc, Biotek Instruments Inc, Axxam SpA, Agilent Technologies Inc, Corning Incorporated, PerkinElmer Inc, Merck Group KGaA, Aurora Biomed Inc, Danaher Corporation, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Cell based assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Lab-on-chip technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biochemical screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Services
  • 7.2.2 By Technology
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Services
  • 7.3.2 By Technology
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Services
  • 7.4.2 By Technology
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Services
  • 7.5.2 By Technology
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Services
  • 7.6.2 By Technology
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIGH-THROUGHPUT SCREENING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bio-Rad Laboratories Inc
  • 9.2.2 Biotek Instruments Inc
  • 9.2.3 Axxam S.P.A
  • 9.2.4 Agilent Technologies Inc
  • 9.2.5 Corning Incorporated
  • 9.2.6 PerkinElmer Inc
  • 9.2.7 Merck Group KGaA
  • 9.2.8 Aurora Biomed Inc
  • 9.2.9 Danaher Corporation
  • 9.2.10 Thermo Fisher Scientific Inc